Ditchcarbon
  • Contact
  1. Organizations
  2. Adare Pharma Solutions
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 20 days ago

Adare Pharma Solutions Sustainability Profile

Company website

Adare Pharma Solutions, headquartered in the United States, is a leading provider in the pharmaceutical industry, specialising in advanced drug delivery systems and formulation development. Founded in 2014, the company has rapidly established itself as a key player in the market, with a focus on enhancing the bioavailability and stability of complex molecules. With operational facilities across North America and Europe, Adare Pharma Solutions offers a diverse range of services, including customised formulation development, manufacturing, and packaging solutions. Their unique expertise in oral and topical dosage forms sets them apart, enabling clients to bring innovative therapies to market efficiently. Recognised for their commitment to quality and innovation, Adare Pharma Solutions has achieved significant milestones, positioning themselves as a trusted partner for pharmaceutical companies seeking to optimise their product offerings.

DitchCarbon Score

How does Adare Pharma Solutions's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

17

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Adare Pharma Solutions's score of 17 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

16%

Let us know if this data was useful to you

Adare Pharma Solutions's reported carbon emissions

Adare Pharma Solutions, headquartered in the US, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). Without emissions data or reduction initiatives, it is unclear how Adare Pharma Solutions is addressing climate change within its operations. The absence of reported figures suggests a need for enhanced transparency and commitment to sustainability practices in line with industry standards.

How Carbon Intensive is Adare Pharma Solutions's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Adare Pharma Solutions's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Adare Pharma Solutions's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Adare Pharma Solutions is in US, which has a low grid carbon intensity relative to other regions.

Adare Pharma Solutions's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Adare Pharma Solutions has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Adare Pharma Solutions's Emissions with Industry Peers

CoreRx, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

GB
•
Pharmaceutical Preparation Manufacturing
Updated 25 days ago

Frontage Laboratories, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Recipharm

SE
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Societal CDMO, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Bioserv Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy